Title : Potential of antibody-drug conjugates and novel therapeutics in breast cancer management.

Pub. Date : 2014

PMID : 24711706






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Lapatinib, a small-molecule dual inhibitor (TKI) of both HER2 and EGFR (epidermal growth factor receptor) pathways, has an antitumor activity translated into progression-free survival benefit in HER2-positive metastatic patients previously treated with a taxane, an anthracycline, and trastuzumab. taxane epidermal growth factor receptor Homo sapiens